InsidersTradesSigma
Track the TARSUS PHARMACEUTICALS INC stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €3.1bn. The latest transaction was disclosed on 17 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: BOBAK AZAMIAN. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
TARSUS PHARMACEUTICALS INC is a pharmaceutical company focused on developing innovative treatments for eye diseases. It is listed on NASDAQ under the ticker TARS.